Home > News > Starpharma Honoured with Frost & Sullivan Award
August 4th, 2005
Starpharma Honoured with Frost & Sullivan Award
Abstract:
Starpharma Holdings Limited today announced that it has received the 2005 Frost & Sullivan Growth Strategy Leadership Award in recognition of the company’s development of VivaGel™ and other polyvalent dendrimer-based products relating to the world nanobiotechnology market. (PDF)
Source:
Starpharma
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||